£795.00

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 3 months

The 2023 Report on Multiple Sclerosis Therapeutics: World Market Segmentation by City

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 86 days · 86 data points (no recent data)

Historical
Generating forecast…
£795.00 £755.25 £771.15 £787.05 £802.95 £818.85 £834.75 27 July 2026 17 August 2026 07 September 2026 28 September 2026 20 October 2026
View at Amazon ↗

Price data checked 5 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 86 days • 1 price levels

Days at Price
86 days 0 22 43 65 86 £795 Days at Price

Price Analysis

Most common price: £795 (86 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 86 days

Description

This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major city of the world. It then ranks these cities and reports them in terms of their size as a percent of the country where they are located, their geographic region (e.g. Africa, Asia, Europe, Middle East, North America, Latin America), and the total world market. In this report we define the sales of multiple sclerosis therapeutics as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AbbVie, Bayer, Biogen, Genzyme, Merck & Company, Mitsubishi Tanabe, Novartis, Pfizer, Sanofi, and Teva. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 June 2022
Listed Since
12 July 2022

Similar Products You Might Like

The 2016 Report on Multiple Sclerosis Therapeutics: World Market Segmentation by City
99% match

The 2016 Report on Multiple Sclerosis Therapeutics: World Market Segmentation by City

£995.00 21 Aug 2026
The 2023 Report on Multiple Sclerosis Treatments: World Market Segmentation by City
99% match

The 2023 Report on Multiple Sclerosis Treatments: World Market Segmentation by City

£795.00 30 Sep 2026
The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States
98% match

The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States

£595.00 20 Aug 2026
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India
97% match

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in India

£515.00 14 Aug 2026
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in the United States
97% match

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in the United States

£520.00 14 Aug 2026
Multiple Sclerosis - Pathways, Diagnosis and Therapeutic Targets (Nervous System and Mental Health)
97% match

Multiple Sclerosis - Pathways, Diagnosis and Therapeutic Targets (Nervous System and Mental Health)

IntechOpen

£114.00 15 Oct 2026
The 2025-2030 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis
97% match

The 2025-2030 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis

£790.00 20 Aug 2026
Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments
97% match

Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments

IntechOpen

£114.00 08 Sep 2026
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in Japan
97% match

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis in Japan

£495.00 12 Aug 2026
Multiple Sclerosis in Children and Adolescents Book
97% match

Multiple Sclerosis in Children and Adolescents Book

Price unavailable
Living with Multiple Sclerosis: A Group-Based Psychological Support Intervention for Newly Diagnosed People with MS (LiMS)
97% match

Living with Multiple Sclerosis: A Group-Based Psychological Support Intervention for Newly Diagnosed People with MS (LiMS)

Routledge

£93.79 15 Oct 2026
Multiple Sclerosis
97% match

Multiple Sclerosis

IntechOpen

£118.98 19 Sep 2026
Clinical Aspects of Multiple Sclerosis Essentials and Current Updates
97% match

Clinical Aspects of Multiple Sclerosis Essentials and Current Updates

Elsevier

£109.99 14 Oct 2026
Translational Methods for Multiple Sclerosis Research: 166 (Neuromethods, 166)
96% match

Translational Methods for Multiple Sclerosis Research: 166 (Neuromethods, 166)

Humana

£88.21 02 Sep 2026
Translational Methods for Multiple Sclerosis Research: 166 (Neuromethods, 166)
96% match

Translational Methods for Multiple Sclerosis Research: 166 (Neuromethods, 166)

Humana

£136.75 21 Aug 2026
The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis for US Zip Codes
96% match

The 2023-2028 Outlook for Beta Interferon Therapeutics for Multiple Sclerosis for US Zip Codes

£490.00 06 Sep 2026
Multiple Sclerosis: Present and Future: 16 (Ettore Majorana International Science Series, 16)
96% match

Multiple Sclerosis: Present and Future: 16 (Ettore Majorana International Science Series, 16)

Springer

£74.84 14 Oct 2026
The 2023 Report on Psoriasis Medicines: World Market Segmentation by City
96% match

The 2023 Report on Psoriasis Medicines: World Market Segmentation by City

£795.00 01 Oct 2026
The 2023 Report on Advanced Therapy Medicinal Products: World Market Segmentation by City
96% match

The 2023 Report on Advanced Therapy Medicinal Products: World Market Segmentation by City

£795.00 16 Aug 2026
New Insights into Systemic Sclerosis
96% match

New Insights into Systemic Sclerosis

IntechOpen

£118.98 17 Sep 2026
Emerging Drugs and Targets for Multiple Sclerosis: Volume 70 (Drug Discovery Series)
96% match

Emerging Drugs and Targets for Multiple Sclerosis: Volume 70 (Drug Discovery Series)

Royal Society of Chemistry

£121.26 09 Oct 2026
Systemic Sclerosis - Recent Advances and New Perspectives
96% match

Systemic Sclerosis - Recent Advances and New Perspectives

IntechOpen

£114.00 12 Sep 2026
Neurological Disorders and Imaging Physics, Volume 2: Engineering and clinical perspectives of multiple sclerosis (IOP ebooks)
96% match

Neurological Disorders and Imaging Physics, Volume 2: Engineering and clinical perspectives of multiple sclerosis (IOP ebooks)

Institute of Physics Publishing

£101.26 03 Oct 2026
Exploring Effects of Diet on Multiple Sclerosis - Nutritional Neurosciences
96% match

Exploring Effects of Diet on Multiple Sclerosis - Nutritional Neurosciences

Springer

£156.14 09 Oct 2026